| Primary |
| Drug Use For Unknown Indication |
33.9% |
| Pain |
19.9% |
| Back Pain |
12.5% |
| Product Used For Unknown Indication |
8.7% |
| Anxiety |
2.6% |
| Intervertebral Disc Degeneration |
2.3% |
| Neuralgia |
2.0% |
| Spinal Column Stenosis |
2.0% |
| Depression |
1.8% |
| Arthritis |
1.5% |
| Congenital Cystic Kidney Disease |
1.5% |
| Intentional Overdose |
1.5% |
| Suicide Attempt |
1.5% |
| Breakthrough Pain |
1.3% |
| Diabetes Mellitus |
1.3% |
| Neck Pain |
1.3% |
| Thyroid Disorder |
1.3% |
| Arterial Disorder |
1.0% |
| Cancer Pain |
1.0% |
| Fibromyalgia |
1.0% |
|
| Drug Toxicity |
13.3% |
| Overdose |
12.0% |
| Vomiting |
9.6% |
| Analgesic Drug Level Increased |
4.8% |
| Drug Level Increased |
4.8% |
| Dyspnoea |
4.8% |
| Multiple Injuries |
4.8% |
| Unresponsive To Stimuli |
4.8% |
| Weight Decreased |
4.8% |
| Loss Of Consciousness |
3.6% |
| Narcotic Intoxication |
3.6% |
| Product Quality Issue |
3.6% |
| Product Substitution Issue |
3.6% |
| Somnolence |
3.6% |
| Toxicity To Various Agents |
3.6% |
| Tremor |
3.6% |
| Withdrawal Syndrome |
3.6% |
| Accidental Exposure |
2.4% |
| Application Site Vesicles |
2.4% |
| Arrhythmia |
2.4% |
|
| Secondary |
| Back Pain |
15.9% |
| Pain |
14.3% |
| Drug Use For Unknown Indication |
13.9% |
| Product Used For Unknown Indication |
13.5% |
| Anxiety |
5.2% |
| Intervertebral Disc Degeneration |
4.6% |
| Spinal Column Stenosis |
4.4% |
| Neuralgia |
4.2% |
| Depression |
3.2% |
| Thyroid Disorder |
3.2% |
| Osteoarthritis |
2.8% |
| Arthritis |
2.0% |
| Blood Cholesterol Increased |
2.0% |
| Neck Pain |
2.0% |
| Breakthrough Pain |
1.6% |
| Fibromyalgia |
1.6% |
| Pain Management |
1.6% |
| Gastrooesophageal Reflux Disease |
1.4% |
| Rhinorrhoea |
1.4% |
| Back Disorder |
1.2% |
|
| Respiratory Arrest |
12.7% |
| Nervousness |
9.9% |
| Drug Ineffective |
7.0% |
| Overdose |
7.0% |
| Chest Pain |
5.6% |
| Staphylococcal Infection |
5.6% |
| Unresponsive To Stimuli |
5.6% |
| Weight Decreased |
5.6% |
| Wrong Technique In Drug Usage Process |
5.6% |
| Constipation |
4.2% |
| Poisoning Deliberate |
4.2% |
| Vomiting |
4.2% |
| Drug Interaction |
2.8% |
| Drug Level Increased |
2.8% |
| Dyspnoea |
2.8% |
| Inadequate Analgesia |
2.8% |
| Malaise |
2.8% |
| Nausea |
2.8% |
| Pancreatitis Acute |
2.8% |
| Respiratory Depression |
2.8% |
|
| Concomitant |
| Drug Use For Unknown Indication |
35.0% |
| Product Used For Unknown Indication |
16.4% |
| Pain |
8.2% |
| Head And Neck Cancer |
4.7% |
| Prophylaxis |
4.7% |
| Nuclear Magnetic Resonance Imaging |
3.5% |
| Constipation |
2.8% |
| Diffuse Large B-cell Lymphoma |
2.6% |
| Non-small Cell Lung Cancer |
2.4% |
| Rheumatoid Arthritis |
2.4% |
| Hepatitis C |
2.1% |
| Hypertension |
2.1% |
| Nausea |
1.9% |
| Breast Cancer |
1.7% |
| Neutropenia |
1.7% |
| Sleep Disorder |
1.7% |
| Fluid Replacement |
1.6% |
| Pneumonia |
1.6% |
| Anxiety |
1.4% |
| Bipolar Disorder |
1.4% |
|
| Vomiting |
12.3% |
| Mallory-weiss Syndrome |
8.2% |
| Weight Decreased |
8.2% |
| White Blood Cell Count Decreased |
8.2% |
| Skin Ulcer |
6.8% |
| Cholelithiasis |
5.5% |
| Respiratory Failure |
5.5% |
| Death |
4.1% |
| General Physical Health Deterioration |
4.1% |
| Pneumothorax |
4.1% |
| Renal Failure Acute |
4.1% |
| Thrombocytopenia |
4.1% |
| Traumatic Lung Injury |
4.1% |
| Weight Increased |
4.1% |
| Dyspnoea |
2.7% |
| Fatigue |
2.7% |
| Oedema Peripheral |
2.7% |
| Oral Fungal Infection |
2.7% |
| Pulmonary Haemorrhage |
2.7% |
| Rash |
2.7% |
|
